GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)
| 22.85 Delayed Data As of Dec 13 |  +0.05 / +0.22%Today’s Change | 18.14 Today|||52-Week Range 23.13 | +21.87% Year-to-Date |
Latest GLAXF News | Press Releases
| 3 High-Yield International Dividend Stocks to Consider Buying Now Dec 11 / MotleyFool.com - Paid Partner Content | Is Clovis Oncology Really a Buyout Candidate? Dec 03 / MotleyFool.com - Paid Partner Content |
| Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for Both Dec 10 / MotleyFool.com - Paid Partner Content | 3 Top Growth Stocks to Buy in December Dec 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 22.80 |
| Today’s open | 23.13 |
| Day’s range | 22.85 - 23.13 |
| Volume | 1,236 |
| Average volume (3 months) | 5,418 |
| Market cap | $114.9B |
Data as of 9:30am ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | +143.10% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +5.72% |
| P/E ratio | 15.5 |
| Price/Sales | 2.30 |
| Price/Book | 20.41 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $4.8B |
| Net profit margin | 11.75% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Brentford, Greater London |
Forecasts
